Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06610448 · ClinicalTrials.gov registry record · NA

Wearable Evaluation of Ambulatory Readings for Blood Pressure

A NA study of Uncontrolled Hypertension and Normal Blood Pressure, sponsored by Stephen Juraschek.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06610448 is a NA study of Uncontrolled Hypertension and Normal Blood Pressure that is actively recruiting participants, run by Stephen Juraschek. The registered enrollment target is 100 participants, below the 754-participant average among 10 other Uncontrolled Hypertension trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06610448, a NA study of Uncontrolled Hypertension and Normal Blood Pressure, is actively recruiting participants, sponsored by Stephen Juraschek.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this project is to compare the performance and validity of novel wearable technologies that measure blood pressure (BP) and physical activity with a Spacelabs Ambulatory Blood Pressure Monitoring (ABPM) device.

Interventions

  • DEVICE ABPMPro
  • DEVICE Spacelabs Ambulatory Blood Pressure Monitoring
  • DEVICE Aktiia Blood Pressure
  • DEVICE LiveMetric
  • DEVICE Bpro

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-06-06
Est. Completion 2026-06-30
Phase NA

Sponsor

Stephen Juraschek

1 total trials

What the Registry Record Tells You About NCT06610448

The ClinicalTrials.gov registry entry for NCT06610448 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 754-participant average among 10 other Uncontrolled Hypertension trials with a reported enrollment target (87% lower). The listed sponsor is Stephen Juraschek, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Uncontrolled Hypertension appearing as the primary indexed condition, and to 5 interventions - of which ABPMPro is the first listed.

NCT06610448 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06610448 about?

NCT06610448 is a clinical study titled "Wearable Evaluation of Ambulatory Readings for Blood Pressure". The purpose of this project is to compare the performance and validity of novel wearable technologies that measure blood pressure (BP) and physical activity with a Spacelabs Ambulatory Blood Pressure Monitoring (ABPM) device.

What is the current status of trial NCT06610448?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-06-06. Estimated completion is 2026-06-30.

What conditions does trial NCT06610448 study?

This clinical trial studies the following conditions: Uncontrolled Hypertension, Normal Blood Pressure, Controlled Hypertension.

What interventions are being tested in trial NCT06610448?

The interventions under investigation include: ABPMPro (DEVICE), Spacelabs Ambulatory Blood Pressure Monitoring (DEVICE), Aktiia Blood Pressure (DEVICE), LiveMetric (DEVICE), Bpro (DEVICE).

Who is sponsoring clinical trial NCT06610448?

This trial is sponsored by Stephen Juraschek, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06610448 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Uncontrolled Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.